期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Uremic clearance granule combined with Alprostadil in the treatment of chronic renal failure: A systematic review and meta-analysis
1
作者 Jing Gan Ya-Fang Guo +3 位作者 Dong-Dong Li zi-zheng zhou Jia-Bao zhou Jian-Dong Gao 《TMR Theory and Hypothesis》 2019年第3期195-203,共9页
Objective: To evaluate whether the combination of Uremic clearance granule with Alprostadil is superior to Alprostadil alone for CRF. Methods: Relevant RCTs were searched through March 2019. Data were analyzed by Stat... Objective: To evaluate whether the combination of Uremic clearance granule with Alprostadil is superior to Alprostadil alone for CRF. Methods: Relevant RCTs were searched through March 2019. Data were analyzed by Stata 15.0. Results: Nine articles involving 726 patients were enrolled in this study. Meta-analysis showed that the total effective rate [OR = 3.68 (2.44, 5.55), P < 0.001], Scr [SMD =-2.34 (-3.49,-1.19), P < 0.001], BUN [SMD =-1.80 (-2.73,-0.87), P < 0.001], Ccr [SMD = 0.71 (0.44, 0.97), P < 0.001] were better in the experimental group. But there were no significant difference in UA, CysC, 24h-Upro and incidence of adverse reactions (all P > 0.05) between two groups. No serious adverse reactions were found. Conclusions: The effect of the integrated medicine on CRF was better than Alprostadil alone. Uremic clearance granule is safe and has no obvious adverse reactions. 展开更多
关键词 UREMIC CLEARANCE GRANULE Chronic RENAL Failure ALPROSTADIL META-ANALYSIS
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部